Evidence map›Paper›PMID 32421440›Full record

Trial reportJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Implementation of Minimally Invasive Esophagectomy From a Randomized Controlled Trial Setting to National Practice.

Sheraz R Markar, Melody Ni, Suzanne S Gisbertz, Leonie van der Werf, Jennifer Straatman, Donald van der Peet, Miguel A Cuesta, George B Hanna, Mark I van Berge Henegouwen, Dutch Upper GI Cancer Audit and TIME Study Group

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 4 pooled it
12.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 4 syntheses or guidelines pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Current Gallstone Treatment Methods, State of the Art.Diseases (Basel, Switzerland) · 2024
    Review
  15. Surgical options in retrosternal oesophageal reconstruction.Langenbeck's archives of surgery · 2024
    Article
  16. History and evidence for state of the art of lymphadenectomy in esophageal cancer surgery.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Sheraz R MarkarDepartment Surgery and Cancer, Imperial College London, London, United Kingdom.
Melody NiDepartment Surgery and Cancer, Imperial College London, London, United Kingdom.
Suzanne S GisbertzDepartment of Surgery, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
Leonie van der WerfDepartment of Surgery, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
Jennifer StraatmanDepartment of Surgery, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
Donald van der PeetDepartment of Surgery, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
Miguel A CuestaDepartment of Surgery, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
George B HannaDepartment Surgery and Cancer, Imperial College London, London, United Kingdom.
Mark I van Berge HenegouwenDepartment of Surgery, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
Dutch Upper GI Cancer Audit and TIME Study Group
Imperial College London · GBUniversity of Amsterdam · NLVrije Universiteit Amsterdam · NLAmsterdam University Medical Centers · NL

Funding

Department of Health
6 · The paper itself

Abstract

purposeThe aim of this study was to examine the external validity of the randomized TIME trial, when minimally invasive esophagectomy (MIE) was implemented nationally in the Netherlands, using data from the Dutch Upper GI Cancer Audit (DUCA) for transthoracic esophagectomy.

methodsOriginal patient data from the TIME trial were extracted along with data from the DUCA dataset (2011-2017). Multivariate analysis, with adjustment for patient factors, tumor factors, and year of surgery, was performed for the effect of MIE versus open esophagectomy on clinical outcomes.

resultsOne hundred fifteen patients from the TIME trial (59 MIE

conclusionWhen adopted nationally outside the TIME trial, MIE was associated with an increase in total and pulmonary complications and reoperation rate. This may reflect nonexpert surgeons outside of high-volume centers performing this minimally invasive technique in a nonstandardized fashion outside of a controlled environment.

Indexed as

EsophagectomyFemaleHumansMaleMiddle AgedMinimally Invasive Surgical ProceduresMultivariate AnalysisTreatment Outcome

Identifiers

PMID32421440
PMCPMC7325364
OpenAlexW3028047396

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.